uroporphyrin i has been researched along with Disease Models, Animal in 3 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Beika, M; Fujiwara, H; Harada, Y; Koizumi, N; Konishi, H; Minamikawa, T; Murayama, Y; Otsuji, E; Shiozaki, A; Takamatsu, T; Tanaka, H; Yamaoka, Y | 1 |
| Azuero-Dajud, R; Bragazzi Cunha, J; Elenbaas, JS; Ferguson, AC; Griffin, MS; Kuo, N; Lentz, SI; Maitra, D; Omary, MB; Shavit, JA | 1 |
| Costet, P; Daniel, JY; de Verneuil, H; Dubus, P; Ged, C; Lalanne, M; Lamrissi-Garcia, I; Mazurier, F; Mendez, M; Moreau-Gaudry, F; Robert, E | 1 |
3 other study(ies) available for uroporphyrin i and Disease Models, Animal
| Article | Year |
|---|---|
Accumulation of Uroporphyrin I in Necrotic Tissues of Squamous Cell Carcinoma after Administration of 5-Aminolevulinic Acid.
Topics: Aged; Aminolevulinic Acid; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Models, Animal; Esophageal Neoplasms; Female; Humans; Male; Mice; Middle Aged; Models, Biological; Necrosis; Spectrometry, Fluorescence; Uroporphyrins | 2021 |
Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models.
Topics: Acitretin; Animals; Bone and Bones; Bone Development; Cell Line; Disease Models, Animal; Porphyria, Erythropoietic; Uroporphyrins; Zebrafish | 2021 |
A knock-in mouse model of congenital erythropoietic porphyria.
Topics: Amino Acid Substitution; Animals; Bone Marrow Transplantation; Disease Models, Animal; Genetic Therapy; Mice; Mice, Transgenic; Mutation, Missense; Porphyria, Erythropoietic; Uroporphyrinogen III Synthetase; Uroporphyrins | 2006 |